EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Newcastle disease burden in Nepal and efficacy of Tablet I2 vaccine in commercial and backyard poultry production

Rajindra Napit iD, Ajit Poudel iD, Saman M Pradhan, Prajwol Manandhar, Sajani Ghaju, Ajay N Sharma, Jyotsna Joshi, Suprim Tha, Kavya Dhital, Udaya Rajbhandari, Amit Basnet, Jessica S Schwind und 2 weitere

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0280688 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Rajindra Napit und 13 weiteren Autor:innen. Beteiligte Einrichtung: Biovac Nepal Pvt. Ltd, Banepa, Kavre, Nepal. Hauptthemen laut MEDLINE: Newcastle Disease, Influenza, Human, Poultry Diseases. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Netherland Enterprize agency-PSI grant, InnovationXchange grant from DFAT.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Poultry ( Gallus domesticus ) farming plays an important role as an income generating enterprise in a developing country like Nepal, contributing more than 4% to the national Gross Domestic Product (GDP). Newcastle Disease (ND) is a major poultry disease affecting both commercial and backyard poultry production worldwide. There were more than 90 reported ND outbreaks in Nepal in 2018 with over 74,986 birds being affected. ND is responsible for over 7% of total poultry mortality in the country. Recent outbreaks of ND in 2021 affected many farms throughout Nepal and caused massive loss in poultry production. ND is caused by a single-stranded ribonucleic acid (RNA) virus that presents very similar clinical symptoms as Influenza A (commonly known as bird flu) adding much complexity to clinical disease identification and intervention. We conducted a nationwide ND and Influenza A (IA) prevalence study, collecting samples from representative commercial and backyard poultry farms from across the major poultry production hubs of Nepal. We used both serological and molecular assessments to determine disease exposure history and identification of strains of ND Virus (NDV). Of the 40 commercial farms tested, both NDV (n = 28, 70%) and IAV (n = 11, 27.5%) antibodies were detected in majority of the samples. In the backyard farms (n = 36), sero-prevalence of NDV and IAV were 17.5% (n = 7) and 7.5% (n = 3) respectively. Genotype II NDV was present in most of the commercial farms, which was likely due to live vaccine usage. We detected never reported Genotype I NDV in two backyard farm samples. Our investigation into 2021 ND outbreak implicated Genotype VII.2 NDV strain as the causative pathogen. Additionally, we developed a Tablet formulation of the thermostable I2-NDV vaccine (Ranigoldunga ™ ) and assessed its efficacy on various (mixed) breeds of chicken ( Gallus domesticus ). Ranigoldunga ™ demonstrated an overall efficacy >85% with a stability of 30 days at room temperature (25°C). The intraocularly administered vaccine was highly effective in preventing ND, including Genotype VII.2 NDV strain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Newcastle DiseaseInfluenza, HumanPoultry DiseasesAnimalsHumansPoultryNepalNewcastle disease virusChickensVaccines, AttenuatedGenotype

Substanzen

Vaccines, Attenuated

Autor:innen und Institutionen

  • Biovac Nepal Pvt. Ltd, Banepa, Kavre, Nepal.
  • Center for Molecular Dynamics Nepal, Kathmandu, Nepal.
  • Institute for Health Logistics & Analytics, Georgia Southern University, Statesboro, Georgia, United States of America.
  • Department of Biological Sciences, University of Queensland, Queensland, Australia.

ORCID-Profile: Rajindra Napit, Ajit Poudel, Dibesh B Karmacharya

Förderung

  • Netherland Enterprize agency-PSI grant
  • InnovationXchange grant from DFAT

Zitieren

APA

Napit, R., Poudel, A., Pradhan, S. M., Manandhar, P., Ghaju, S., Sharma, A. N., Joshi, J., Tha, S., Dhital, K., Rajbhandari, U., Basnet, A., Schwind, J. S., Rajbhandari, R. M., & Karmacharya, D. B. (2023). Newcastle disease burden in Nepal and efficacy of Tablet I2 vaccine in commercial and backyard poultry production. PLOS ONE. https://doi.org/10.1371/journal.pone.0280688

Vancouver

Napit R, Poudel A, Pradhan SM, Manandhar P, Ghaju S, Sharma AN, et al. Newcastle disease burden in Nepal and efficacy of Tablet I2 vaccine in commercial and backyard poultry production. PLOS ONE. 2023. doi:10.1371/journal.pone.0280688

BibTeX
@article{Napit2023,
  author = {Napit, Rajindra and Poudel, Ajit and Pradhan, Saman M and Manandhar, Prajwol and Ghaju, Sajani and Sharma, Ajay N and Joshi, Jyotsna and Tha, Suprim and Dhital, Kavya and Rajbhandari, Udaya and Basnet, Amit and Schwind, Jessica S and Rajbhandari, Rajesh M and Karmacharya, Dibesh B},
  title = {Newcastle disease burden in Nepal and efficacy of Tablet I2 vaccine in commercial and backyard poultry production},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0280688}
}
Kostenlos starten →